- Record: found
- Abstract: found
- Article: not found
Pegloticase failure and a possible solution: Immunosuppression to prevent intolerance and inefficacy in patients with gout.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Pegloticase is a highly effective therapy for patients with refractory and/or tophaceous gout, but has a high discontinuation rate (30-50%) due to development of anti-drug antibodies causing loss of efficacy and risk of infusion reactions.